Market Overview:
The global creatinine measurement market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market was valued at US$ 1,362.8 Mn in 2017 and is projected to reach US$ 2,023.4 Mn by 2030. The enzymatic method is the dominant type, which accounting for over 72% sales share in terms of volume in 2018., Creatinine Measurement has various applications such as Hospitals, Diagnostic Laboratories etc. Some factors that are driving the growth of this market include increasing prevalence of renal diseases.
Product Definition:
A creatinine measurement is a blood test that is used to determine how well the kidneys are working. The test measures the level of creatinine in the blood. Creatinine is a waste product that is produced when muscle tissue breaks down. High levels of creatinine indicate that the kidneys are not working properly.
Jaffe's Kinetic Method:
The Jaffe's kinetic method is a rapid and sensitive method for measuring the creatinine level in serum or plasma. This method provides accurate results as compared to the enzymatic methods. The sensitivity of this test is higher than other available tests due to its ability to detect very small changes in creatinine levels, which makes it an ideal choice for monitoring patients with critical illnesses such as cardiac disorders, renal failure or diseases that affect the kidney function.
Enzymatic Method:
Enzymatic method is also known as enzymatic degradation or proteolytic degradation. It is a type of chemical reaction that involves the use of catalysts to break down proteins into amino acids and smaller peptides. The process yields an accurate measurement for creatinine which helps in monitoring the kidney function.
Application Insights:
Based on application, the global creatinine measurement market is segmented into hospitals, diagnostic laboratories and hospital outpatient departments, and hospitals. The hospital segment held a significant share in terms of applications in 2018. This can be attributed to the presence of key players offering high quality services along with advanced technologies for diagnosis at low costs which eventually benefits patients across the globe. For instance, as per WHO Global Database on Creatinine Measurement there are more than 200 laboratories serving over 50 million people within 150 miles radius of ZIP code 33000 (New York) which provides access to approximately 23 million people within USA alone. Thus such factors are contributing towards growth of this segment globally thereby benefiting overall market growth during forecast period.
The other important factor contributing towards increased utilization rates at lower cost is technological advancement made by major manufacturers like Quest Diagnostics.
Regional Analysis:
North America dominated the global creatinine measurement market in 2018. This can be attributed to the presence of key players, such as Abbott Laboratories; Roche Diagnostics Corporation; and Alere Inc.; in this region. The increasing prevalence of kidney diseases is also one of the major factors responsible for market growth. For instance, according to data published by National Kidney Foundation about 60 million people are living with some form of kidney disease in U.S., which is expected to increase up to 95 million by 2050 if nothing changes (1). In addition, growing number of government initiatives and awareness programs regarding CKD are also contributing towards regional growth (2).
Asia Pacific is expected witness lucrative CAGR over the forecast period owing to rising healthcare expenditure coupled with improving healthcare infrastructure especially in developing countries like India and China (3).
Growth Factors:
- Increasing incidence of renal diseases and disorders
- Growing awareness about the benefits of early diagnosis and treatment of renal diseases
- Rising demand for point-of-care diagnostics devices
- Technological advancements in creatinine measurement devices and kits
- Growing number of clinical studies on creatinine measurement
Scope Of The Report
Report Attributes
Report Details
Report Title
Creatinine Measurement Market Research Report
By Type
Jaffe's Kinetic Method, Enzymatic Method, Enzymatic method is the dominated type, which accounting for over 72% sales share in terms of volume in 2018., Creatinine Measuremen
By Application
Hospitals, Diagnostic Laboratories, Hospitals hold an important share in terms of applications with a market share of over 78% in 2018.
By Companies
Roche, Siemens Healthineers, Danaher, Abbott, BSBE, Maccura Biotechnology, Leadman Biochemis, Mindray, Fujifilm, KANTO CHEMICAL, Reebio, Weigao, Homa, Anhui Daqian, Fosun Pharma, Creatinine Measuremen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Creatinine Measurement Market Report Segments:
The global Creatinine Measurement market is segmented on the basis of:
Types
Jaffe's Kinetic Method, Enzymatic Method, Enzymatic method is the dominated type, which accounting for over 72% sales share in terms of volume in 2018., Creatinine Measuremen
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Laboratories, Hospitals hold an important share in terms of applications with a market share of over 78% in 2018.
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Siemens Healthineers
- Danaher
- Abbott
- BSBE
- Maccura Biotechnology
- Leadman Biochemis
- Mindray
- Fujifilm
- KANTO CHEMICAL
- Reebio
- Weigao
- Homa
- Anhui Daqian
- Fosun Pharma
- Creatinine Measuremen
Highlights of The Creatinine Measurement Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Jaffe's Kinetic Method
- Enzymatic Method
- Enzymatic method is the dominated type, which accounting for over 72% sales share in terms of volume in 2018.
- Creatinine Measuremen
- By Application:
- Hospitals
- Diagnostic Laboratories
- Hospitals hold an important share in terms of applications with a market share of over 78% in 2018.
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Creatinine Measurement Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Creatinine is a waste product that is created when the body breaks down muscle tissue. Creatinine levels are used to monitor kidney function.
Some of the major players in the creatinine measurement market are Roche, Siemens Healthineers, Danaher, Abbott, BSBE, Maccura Biotechnology, Leadman Biochemis, Mindray, Fujifilm, KANTO CHEMICAL, Reebio, Weigao, Homa, Anhui Daqian, Fosun Pharma, Creatinine Measuremen.
The creatinine measurement market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Creatinine Measurement Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Creatinine Measurement Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Creatinine Measurement Market - Supply Chain
4.5. Global Creatinine Measurement Market Forecast
4.5.1. Creatinine Measurement Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Creatinine Measurement Market Size (000 Units) and Y-o-Y Growth
4.5.3. Creatinine Measurement Market Absolute $ Opportunity
5. Global Creatinine Measurement Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Creatinine Measurement Market Size and Volume Forecast by Type
5.3.1. Jaffe's Kinetic Method
5.3.2. Enzymatic Method
5.3.3. Enzymatic method is the dominated type, which accounting for over 72% sales share in terms of volume in 2018.
5.3.4. Creatinine Measuremen
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Creatinine Measurement Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Creatinine Measurement Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Diagnostic Laboratories
6.3.3. Hospitals hold an important share in terms of applications with a market share of over 78% in 2018.
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Creatinine Measurement Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Creatinine Measurement Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Creatinine Measurement Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Creatinine Measurement Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Creatinine Measurement Demand Share Forecast, 2019-2026
9. North America Creatinine Measurement Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Creatinine Measurement Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Creatinine Measurement Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Diagnostic Laboratories
9.4.3. Hospitals hold an important share in terms of applications with a market share of over 78% in 2018.
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Creatinine Measurement Market Size and Volume Forecast by Type
9.7.1. Jaffe's Kinetic Method
9.7.2. Enzymatic Method
9.7.3. Enzymatic method is the dominated type, which accounting for over 72% sales share in terms of volume in 2018.
9.7.4. Creatinine Measuremen
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Creatinine Measurement Demand Share Forecast, 2019-2026
10. Latin America Creatinine Measurement Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Creatinine Measurement Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Creatinine Measurement Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Hospitals hold an important share in terms of applications with a market share of over 78% in 2018.
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Creatinine Measurement Market Size and Volume Forecast by Type
10.7.1. Jaffe's Kinetic Method
10.7.2. Enzymatic Method
10.7.3. Enzymatic method is the dominated type, which accounting for over 72% sales share in terms of volume in 2018.
10.7.4. Creatinine Measuremen
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Creatinine Measurement Demand Share Forecast, 2019-2026
11. Europe Creatinine Measurement Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Creatinine Measurement Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Creatinine Measurement Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Hospitals hold an important share in terms of applications with a market share of over 78% in 2018.
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Creatinine Measurement Market Size and Volume Forecast by Type
11.7.1. Jaffe's Kinetic Method
11.7.2. Enzymatic Method
11.7.3. Enzymatic method is the dominated type, which accounting for over 72% sales share in terms of volume in 2018.
11.7.4. Creatinine Measuremen
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Creatinine Measurement Demand Share, 2019-2026
12. Asia Pacific Creatinine Measurement Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Creatinine Measurement Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Creatinine Measurement Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Hospitals hold an important share in terms of applications with a market share of over 78% in 2018.
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Creatinine Measurement Market Size and Volume Forecast by Type
12.7.1. Jaffe's Kinetic Method
12.7.2. Enzymatic Method
12.7.3. Enzymatic method is the dominated type, which accounting for over 72% sales share in terms of volume in 2018.
12.7.4. Creatinine Measuremen
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Creatinine Measurement Demand Share, 2019-2026
13. Middle East & Africa Creatinine Measurement Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Creatinine Measurement Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Creatinine Measurement Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Hospitals hold an important share in terms of applications with a market share of over 78% in 2018.
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Creatinine Measurement Market Size and Volume Forecast by Type
13.7.1. Jaffe's Kinetic Method
13.7.2. Enzymatic Method
13.7.3. Enzymatic method is the dominated type, which accounting for over 72% sales share in terms of volume in 2018.
13.7.4. Creatinine Measuremen
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Creatinine Measurement Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Creatinine Measurement Market: Market Share Analysis
14.2. Creatinine Measurement Distributors and Customers
14.3. Creatinine Measurement Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Siemens Healthineers
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Abbott
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BSBE
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Maccura Biotechnology
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Leadman Biochemis
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Mindray
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Fujifilm
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. KANTO CHEMICAL
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Reebio
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Weigao
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Homa
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Anhui Daqian
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Fosun Pharma
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Creatinine Measuremen
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
